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Abstract
Background: Acute kidney injury (AKI) occurs frequently in
septic patients. Albuminuria may play a role as an early marker of septic AKI. The potential association between de novo
dipstick albuminuria (DA) and septic AKI has not been examined. Methods: We conducted a single-center observational
cohort study of 423 critically ill septic patients without chronic kidney disease (CKD) or prior positive DA within 3 months
before admission. The association between de novo DA
within the first 24 h of presentation and AKI at 72 h was examined. Results: AKI was identified in 268/423 (63%) patients and 20/423 (4.7%) required dialysis. De novo DA was
associated with AKI (univariate OR 1.91; 95% CI 1.27–2.86,
p = 0.002). The association persisted in a multivariate logistic
regression model adjusted for demographics, baseline kidney function, comorbidities, critical illness parameters, and
exposure to nephrotoxins (adjusted OR 1.87; 95% CI 1.21–
2.89, p = 0.005). The association between de novo DA and AKI
was stronger for severe AKI, i.e. Acute Kidney Injury Network
(AKIN) stage 3 (adjusted OR 2.99; 95% CI 1.52–5.85, p = 0.001)
and AKIN stage 2 (adjusted OR 1.79; 95% CI 1.002–3.21, p =
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0.049) but not AKIN stage 1 (adjusted OR 1.41; 95% CI 0.87–
2.29, p = 0.16). Conclusions: De novo DA within the first 24 h
of admission was independently associated with severe AKI
in critically ill septic patients. Future studies are required to
fully elucidate the utility of DA testing in the early detection
and stratification of AKI.
© 2015 S. Karger AG, Basel

Introduction

Sepsis is one of the most common reasons for intensive
care unit (ICU) admissions. It often leads to multiorgan
dysfunction and the kidney is one of the organs frequently affected [1, 2]. Acute kidney injury (AKI) occurs in
about 25% of patients with severe sepsis and in nearly
50% of those with septic shock [3].
Sepsis is marked by the release of a plethora of proinflammatory molecules into the systemic circulation that
leads to a loss of barrier integrity of endothelial cells and
systemic capillary leak [4, 5]. The glomerular manifestation of this enhanced capillary permeability is increased
excretion of albumin in the urine [6]. In experimental
septic AKI, lipopolysaccharide ingestion has been shown
to induce significant ultrastructural alterations in the gloJavier A. Neyra, MD
Division of Nephrology, University of Texas Southwestern Medical Center
5323 Harry Hines Blvd.
Dallas, TX 75390-8516 (USA)
E-Mail Javier.NeyraLozano @ UTSouthwestern.edu

2,252

1,176 patients with positive or absent
DA testing within 3 months before
admission; 16 without SCr within the
first 72 h of admission and 364 without
DA testing within the first 24 h
of admission

696

256 patients with ICD-9-CM codes
for bacterial or fungal UTI and 17
with gross hematuria (erythrocytes
>100/hpf in urinary microscopy)

423

Fig. 1. Cohort derivation. UTI = Urinary

329
(78%)

94
(22%)

DA testing on admission

DA testing within 24 h

tract infection.

merular endothelium, and albuminuria has been detected
within the first 24 h [7]. Furthermore, the renal cortical
albumin gene, usually silent under normal conditions,
has been found to be upregulated in early AKI, contributing to tubular albuminuria [8]. Thus, albuminuria may
play a role as a useful marker for septic AKI.
Microalbuminuria occurs in up to 87% of septic patients [9]. Its presence in sepsis has been shown to predict
vasopressor requirement, organ failure, and ICU survival
[10–12]. Microalbuminuria, defined as 30–300 mg/day of
albumin excretion in the urine, falls below the threshold
detection of conventional urinary dipsticks. However,
there may be a heightened renal excretion of albumin in
septic AKI that may be detected with conventional dipsticks. Accordingly, the purpose of this study was to examine the potential association between de novo dipstick albuminuria (DA) within the first 24 h of ICU admission
and AKI at 72 h.
Subjects and Methods
Study Design and Participants
We conducted a retrospective, observational cohort study utilizing a population-based, ICU database of septic patients admitted to Henry Ford Hospital, an urban, tertiary care hospital in Detroit, Mich., USA, from January 2004 through July 2011. The subject search was done based on Angus criteria [1] for severe sepsis
or septic shock using the International Classification of Diseases,
Ninth Revision, Clinical Modification (ICD-9-CM) codes [13] for
both a bacterial or fungal infection and a diagnosis of acute organ
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dysfunction excluding gastrointestinal failure. Inclusion criteria
comprised adult patients admitted to the ICU with a diagnosis of
severe sepsis or septic shock, a documented serum creatinine (SCr)
and urinalysis within 3 months before admission, urinalysis within the first 24 h of admission, and at least one value of SCr within
the first 72 h of ICU admission. Exclusion criteria consisted of preexisting chronic kidney disease (CKD; baseline SCr >132.6 μmol/l
or >1.5 mg/dl within 3 months before admission), albuminuria
detected by dipstick within 3 months before admission, pregnancy, and potential causes of false-positive albuminuria on dipstick
(erythrocytes >100/hpf in urinary microscopy or bacterial or fungal urinary tract infection ascertained by ICD-9-CM codes). The
protocol was approved by the institutional review board.
Study Variables
The most recent SCr within the 3-month period before ICU
admission was defined as the baseline SCr. The greatest SCr within 72 h of admission was used to determine the diagnosis of AKI,
defined and graded based on Acute Kidney Injury Network
(AKIN) criteria [14], which defines AKI based on SCr- and urine
output-based criteria. In this study, only the SCr criterion was used
given the lack of urine output data. When a patient fulfilled criteria
for more than one AKIN stage within the first 72 h of ICU admission, the higher stage was considered for the purpose of the analysis. De novo DA was defined as new-onset dipstick positive for
albuminuria within the first 24 h of presentation with severe sepsis
or septic shock in a patient who had a documented absence of DA
in the past 3 months. DA was classified as either negative or positive. A positive DA consisted of a semiquantitative result from
‘trace’ to ‘4+ or >300 mg/dl’ (AUTION® Sticks 9EB; Arkray USA,
Edina, Minn., USA). All subject-specific variables were obtained
from electronic medical records by data management personnel
blinded to the study analysis. These included demographic data
(age, gender, and race), comorbidity (diabetes, hypertension, heart
failure, and anemia), baseline SCr, indicators of critical illness
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Table 1. Patient characteristics by DA status

Variable

Negative DA (n = 228)

Positive DA (n = 195)

Comparison p value

Demographics
Age (mean ± SD), years
Male gender
African-American

60.7 ± 16.8
115 (50.4)
120 (52.6)

60.9 ± 18.1
97 (49.7)
121 (62.1)

0.88c
0.89e
0.15e

Chronic conditions
Median baseline SCr (IQR), μmol/l
Median baseline eGFRa (IQR), ml/min/1.73 m2
Diabetes
Hypertension
Systolic heart failure
Anemiab

79.6 (61.9 – 97.2)
90.0 (68.6 – 122.0)
56 (24.6)
102 (44.7)
3 (1.3)
221 (96.9)

79.6 (61.9 – 97.2)
88.9 (70.2 – 109.6)
56 (28.7)
80 (41)
3 (1.5)
190 (97.4)

0.69d
0.84d
0.33e
0.44e
1.00f
0.76e

Drug exposure
Diuretic
Statin
Iodinated contrast
NSAID
Aminoglycoside
Critical indicators
Median ICU length of stay (IQR), days
Vasopressor or inotrope
Mechanical ventilation

88 (38.6)
52 (22.8)
2 (0.9)
14 (6.1)
51 (22.4)
5 (2 – 11.5)
55 (24.1)
107 (46.9)

63 (32.3)
34 (17.4)
1 (0.5)
5 (2.6)
57 (29.2)

0.18e
0.17e
1.00f
0.08e
0.11e

5 (3 – 9)
68 (34.9)
92 (47.2)

0.95d
0.02e, *
0.96e

Values are presented as numbers (%) unless otherwise stated. * p < 0.05. NSAID = Nonsteroidal anti-inflammatory drug.
a Using the 4-variable Modification of Diet in Renal Disease (MDRD) study equation. b Hematocrit <39% for men and <36% for
women. c Two-sided t test. d Wilcoxon rank-sum test. e χ2 test. f Fisher’s exact test.

(inotrope, vasopressor, diuretic use, dialysis, mechanical ventilation, and length of ICU stay), and exposure to nephrotoxins (nonsteroidal anti-inflammatory drugs or aminoglycosides).
Study Outcomes
We tested for the presence of an independent association between de novo DA within the first 24 h of ICU admission and AKI
at 72 h in this selected sample of ICU patients with severe sepsis or
septic shock.
Statistical Analysis
Microsoft Excel 2010 (Microsoft, Redmond, Wash., USA) and
SAS 9.3 (SAS Institute, Cary, N.C., USA) were used in data acquisition and analysis. Categorical data were reported as percentages
and continuous data as means ± SD or median (IQR) as appropriate. Between-group comparisons for categorical variables were
made using either the χ2 test or Fisher’s exact test when the expected frequencies were <5. For continuous variables, either a
2-sided t test or a Wilcoxon rank-sum test was conducted when
data were not normally distributed. In lieu of nonGaussian distributions, baseline SCr, baseline estimated glomerular filtration rate
(eGFR), and ICU length of stay (days) were natural log transformed. All of the associations between potential confounders and
AKI were tested by univariate logistic regression. A multivariate
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logistic regression model was constructed for AKI and different
stages of AKIN as the dependent variables and de novo DA (dichotomized as positive or negative) as the main independent variable. This model included all covariates that may potentially be
associated with AKI. Finally, a multivariate logistic regression
model that adjusts for baseline kidney function was constructed
using candidate variables that had a p value <0.1 in the univariate
models. The same model was used to test the association between
each of AKIN stages 1–3 and de novo DA. The 95% CI reported
for the logistic regression OR were based on the Wald estimation.
p < 0.05 was considered statistically significant.

Results

We identified 2,252 adult patients admitted to the ICU
with the diagnosis of severe sepsis or septic shock and
documented SCr ≤132.6 μmol/l (1.5 mg/dl) within 3
months before indexed admission during the study dates.
Of these, 423 patients met all inclusion and exclusion criteria (fig. 1). The baseline characteristics of the study paNephron Clin Pract 2014;128:373–380
DOI: 10.1159/000368902
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Table 2. Univariate association between de novo DA within the
first 24 h of ICU admission and AKI and adverse in-hospital outcomes

AKI at 72 h of ICU admission
All AKI
129 (56.6)
AKIN 1
75 (43.1)
AKIN 2
35 (26.1)
AKIN 3
19 (16.1)
Adverse in-hospital outcomes
In-hospital mortality
51 (22.4)
In-hospital dialysis
13 (5.7)

Positive DA
(n = 195)

Comparison
p value

139 (71.3)
65 (53.7)
37 (39.8)
37 (39.8)

<0.01a, *
0.07a
0.03a, *
<0.01a, *

51 (26.2)
7 (3.6)

0.36a
0.31

tients, including demographic data, comorbidities, baseline SCr, indicators of critical illness, and exposure to potential nephrotoxins, are reported in table 1. No significant
differences were found among patients with positive DA
versus negative DA, except for the more frequent use of
vasoactive drugs (e.g. vasopressor or inotrope agents) in
the positive DA group. The most common diuretic utilized was furosemide, which was administered approximately 90% of the time when a diuretic was given within
the first 72 h of ICU admission.
Of the 423 patients studied, 268 (63%) developed AKI
within the first 72 h of ICU admission based on AKIN criteria. Of those who developed AKI, 140 (52%) were at
stage 1, 72 (27%) were at stage 2, and 56 (21%) were at
stage 3. Twenty (4.7%) patients required dialysis during
the hospital admission. Urine dipstick testing was performed either at the time of ICU admission (in 78% of the
patients) or during the course of the first day of ICU admission (in 22% of the patients) (fig. 1). De novo DA within the first 24 h of ICU admission was found in 195 (46%)
of the patients. AKI occurred more often in patients with
de novo DA (table 2; fig. 2a). The semiquantitative severity categories of DA readings for each AKIN stage of AKI
are reported in figure 2b. A total of 102 patients (24%) died
during hospital admission. The mortality rate was 28%
when patients developed AKI and 17% if they did not
(p = 0.01). Of the 268 patients who developed AKI, 128
(48%) progressed to a higher AKIN stage within the first
72 h of admission. De novo DA was present in 74 (58%)
but absent in 54 (42%) of these patients (p = 0.06).
Nephron Clin Pract 2014;128:373–380
DOI: 10.1159/000368902

50
40

*

*

AKIN 2

AKIN 3

30
20
10

a

a

Values are presented as numbers (%) unless otherwise stated.
* p < 0.05.
a χ2 test.
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60
Patients (%)

Negative DA
(n = 228)

DA negative
DA positive

*

70

0
All AKI
60

AKIN 1

AKIN 1
AKIN 2
AKIN 3

50
Patients (%)

Variable

80

40
30
20
10

b

0
Trace

30 mg/dl 100 mg/dl 300 mg/dl >300 mg/dl

Fig. 2. a Univariate association between de novo DA within the
first 24 h of ICU admission and AKI at 72 h. b Semiquantitative

severity categories of DA readings within the first 24 h of ICU admission for each AKIN stage of AKI at 72 h. * p < 0.05.

Univariate analysis showed a significant association
between de novo DA within the first 24 h of ICU admission and AKI at 72 h (OR 1.91; 95% CI 1.27–2.86, p =
0.002) (table 3). The association persisted in a multivariate analysis that adjusted for age, gender, race, baseline
SCr, comorbidities, critical illness parameters, and exposure to nephrotoxins (adjusted OR 1.87; 95% CI 1.21–
2.89, p = 0.005) (table 3). The association between de
novo DA and AKI was stronger for severe AKI, i.e. AKIN
3 (adjusted OR 2.99; 95% CI 1.52–5.85, p = 0.001) and
AKIN 2 (adjusted OR 1.79; 95% CI 1.002–3.21, p = 0.049)
but not AKIN 1 (adjusted OR 1.41; 95% CI 0.87–2.29,
p = 0.16) (table 4). Also, the association between de novo
DA and in-hospital dialysis was not statistically significant (p = 0.44), attributable to the low number of these
events (n = 20) in the entire cohort.
Other important predictors of AKI in our regression
models were diabetes (adjusted OR 1.99; 95% CI 1.22–
Neyra /Manllo /Li /Jacobsen /Yee /
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Table 3. Association between de novo DA within the first 24 h of ICU admission and AKI at 72 h

Variable

Univariate OR
(95% CI)

p value

Multivariate OR
(95% CI)

p value

Multivariate OR
(95% CI)

p value

De novo DA
Age (years)
Male gender
African-American vs. white
White vs. other
Baseline SCr (μmol/l)
Diabetes
Hypertension
Systolic heart failure
Anemiaa
Diuretic
Statin
Iodinated contrast
NSAID
Aminoglycoside
Vasopressor or inotrope
Mechanical ventilation

1.91 (1.27−2.86)
1.00 (0.99−1.02)
1.07 (0.72−1.59)
0.67 (0.32−1.42)
0.70 (0.32−1.52)
0.81 (0.45−1.48)
1.95 (1.21−3.15)
0.99 (0.66−1.47)
0.28 (0.05−1.57)
3.59 (1.06−12.10)
1.33 (0.87−2.02)
0.71 (0.44−1.16)
0.29 (0.03 – 3.19)
0.50 (0.20 – 1.27)
1.09 (0.69−1.72)
1.87 (1.18−2.96)
1.33 (0.89−1.98)

0.002*
0.571
0.734
0.359
0.539
0.499
0.006*
0.950
0.149
0.040*
0.183
0.170
0.309
0.146
0.716
0.008*
0.162

1.87 (1.21−2.89)
1.00 (0.99−1.01)
1.18 (0.76−1.83)
0.60 (0.27−1.34)
0.69 (0.30−1.58)
0.74 (0.36−1.51)
2.29 (1.35−3.9)
1.09 (0.70−1.71)
0.20 (0.03−1.23)
3.76 (1.03−13.70)
1.57 (0.97−2.54)
0.60 (0.35−1.03)
0.26 (0.02−3.13)
0.48 (0.18−1.29)
0.73 (0.44−1.22)
1.61 (0.97−2.68)
1.27 (0.81−2.01)

0.005*
0.804
0.464
0.213
0.663
0.407
0.002*
0.694
0.083
0.045*
0.070
0.066
0.291
0.147
0.230
0.065
0.301

1.79 (1.18−2.71)
–
–
–
–
0.76 (0.41−1.41)
1.99 (1.22−3.24)
–
–
–
–
–
–
–
–
1.80 (1.12−2.88)
–

0.006*
–
–
–
–
0.376
0.006*
–
–
–
–
–
–
–
–
0.015*
–

Data are presented in 3 models: a univariate model, a multivariate logistic regression model that adjusts for all variables, and a final
model that adjusts for baseline SCr and for covariates that were retained in backward selection. For all dichotomous categorical covariates the reference is the ‘nonoccurrence’ of that covariate. * p < 0.05. NSAID = Nonsteroidal anti-inflammatory drug.
a Hematocrit <39% for men and <36% for women.

Table 4. Multivariate logistic regression analysis adjusted for potential confounders relating de novo DA to AKIN staging

Variable

Multivariate
AKIN 1 OR
(95% CI)

p value

Multivariate
AKIN 2 OR
(95% CI)

p value

Multivariate
AKIN 3 OR
(95% CI)

p value

De novo DA
Diabetes
Vasopressor or inotrope
Baseline SCr (μmol/l)

1.41 (0.87−2.29)
2.10 (1.22−3.63)
1.42 (0.82−2.48)
1.51 (0.72−3.17)

0.160
0.008*
0.214
0.275

1.79 (1.002−3.21)
1.78 (0.90−3.52)
1.95 (1.03−3.71)
0.44 (0.19−1.02)

0.049*
0.096
0.041*
0.055

2.99 (1.52−5.85)
2.15 (1.00−4.64)
2.86 (1.44−5.70)
0.32 (0.12−0.86)

0.001*
0.051
0.003*
0.023*

The analysis always adjusted for baseline SCr irrespectively of statistical significance. In addition, all AKIN stages were adjusted by
diabetes status and vasopressor or inotrope requirement. * p < 0.05.

3.24, p = 0.006) and the use of vasoactive agents, i.e. vasopressor or inotropic drugs (adjusted OR 1.8; 95% CI 1.12–
2.88, p = 0.015). We also performed a sensitivity analysis
in which trace DA was adjudicated as negative and not
positive as previously reported. We found an even stronger association between de novo DA within the first 24 h
and AKI at 72 h (OR 2.11; 95% CI 1.29–3.47, p = 0.003).
In the multivariate model, this association remained significant (adjusted OR 1.89; 95% CI 1.14–3.14, p = 0.013).
DA and Septic AKI

Discussion

AKI is a serious medical condition associated with
high morbidity and mortality [15]. Early detection of
AKI may facilitate timely intervention and mitigate kidney damage. Unfortunately, early detection of AKI is difficult and existing biomarkers of early injury have not yet
been implemented in routine clinical practice [16]. Furthermore, the concept of subclinical AKI has emerged,
Nephron Clin Pract 2014;128:373–380
DOI: 10.1159/000368902
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that is, tubular damage without functional loss [17], and
several initiatives to prevent and treat AKI are underway
[18].
The presence of albuminuria, a classical risk marker of
kidney disease, is becoming a red flag in the assessment
of kidney risk profiles. In a population cohort, preexistent, heavy albuminuria (urine dipstick ≥2+) predicted
hospital admissions for AKI in patients with a preserved
baseline kidney function [19]. Likewise, in the Atherosclerosis Risk in Communities population-based cohort,
even high-normal urine albumin-to-creatinine ratios
(10–29 mg/g) independently increased the risk of incident AKI in a fashion similar to decreased eGFR [20].
Moreover, in a retrospective cohort of 402 trauma patients who received intravenous contrast, the strongest
predictor of contrast-induced AKI was albuminuria measured by dipstick [21]. Similarly, positive urine dipstick
readings independently predicted the development of
AKI in a retrospective cohort of 396 patients with severe
burns [22]. Recently, Molnar et al. [23] demonstrated that
early postoperative albuminuria improved the prediction
of AKI in a prospective cohort of 1,198 patients undergoing cardiac surgery. DA (≥100 mg/dl) was associated with
the greatest risk for AKI.
Albuminuria has also shown utility in critically ill patients. In a small prospective cohort study, increasing microalbuminuria levels over the first 48 h predicted hospital mortality and had a high negative predictive value for
the development of AKI and multiple organ failure in the
ICU setting [11]. Additionally, microalbuminuria was
proposed as a biomarker of systemic capillary permeability in sepsis and a useful predictor of ICU survival in comparison to common acute physiologic scores [9, 12].
Sepsis results from an overproduction of inflammatory mediators as a consequence of the interaction of the
human immune system with pathogens and bacterial wall
constituents in the body [4]. A very early feature of inflammation is endothelial dysfunction and increased capillary permeability to plasma proteins, which occurs within a few minutes of injury and is amplified by the kidney
[24, 25]. The glomerular manifestation of this enhanced
capillary permeability is increased excretion of albumin
in the urine [6].
Recently, animal models of AKI have been used to hypothesize the occurrence of albuminuria based on: (1)
glomerular hyperfiltration, (2) glomerular injury and endothelial dysfunction, (3) tubular injury and impaired
reabsorption, and (4) ‘renal hepatization’ or albumin
gene induction. Ischemic and toxic forms of AKI can alter the glomerular structure and function, thereby en378
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hancing the permeability to albumin. In a mouse model
of septic AKI, Kato et al. [26] identified decreases in
podocin, CD2-associated protein (CD2AP), and tensin
2, all essential molecules for podocyte structure and
function. In that study, downregulation of these molecules was associated with foot process effacement and
albuminuria after 36 h of injury. Additionally, Schreiber
et al. [27] demonstrated that acute endotoxemia and
ischemia-reperfusion-mediated AKI in mice induced
downregulation of the multiligand receptors megalin
and cubilin which reclaim albumin via proximal tubular
endocytosis. In 2011, Ware et al. [8] described in mouse
models of AKI, including ischemia-reperfusion, renal
cortical expression of the normally silent albumin gene
that promotes albumin secretion and thus exhibits characteristics of an acute tubular stress reactant, analogous
to neutrophil-gelatinase lipocalin (NGAL) or kidney injury molecule-1 (KIM-1). This study also tested the utility of albuminuria as an early predictor of AKI, in comparison to NGAL within the first 24 h of injury, and
determined a greater specificity in experimental AKI
(murine models) and a slightly better receiver-operating
characteristic curve in humans. However, the authors
only studied 15 critically ill ICU patients with AKI and
14 Acute Physiology and Chronic Health Evaluation II
(APACHE II)-matched controls.
Our findings highlight the strong association between
new-onset or de novo DA within the first 24 h of ICU admission and the occurrence of severe AKI at 72 h in patients with severe sepsis or septic shock (e.g. negative predictive values of 92% for AKIN stage 3 and 85% for AKIN
stage 2). This association was not significant for AKIN
stage 1, likely because of the inability to discriminate between prerenal azotemia and intrinsic kidney injury at
this mild stage of AKI. We believe that new-onset albuminuria may serve as an inexpensive biomarker in critically ill patients at risk of AKI, although it should be rigorously tested with receiver-operating characteristic
analysis and performance and reclassification metrics in
larger and prospective studies.
The strengths of our study include the utilization of a
universally accepted definition of AKI and the use of 2
different multivariable models to adjust for confounders.
Unique to our study is the exclusion of patients with advanced CKD (SCr >132.6 μmol/l or >1.5 mg/dl) and/or
prior positive DA, as well as common causes of falsepositive DA such as bacterial or fungal urinary tract infection and gross hematuria. The selection of a study
sample with negative DA within 3 months prior to admission allowed us to search for the association between
Neyra /Manllo /Li /Jacobsen /Yee /
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truly new-onset or de novo DA and AKI. This was not
done in prior studies searching for this association. Aside
from the retrospective nature of this investigation, 2 important limitations are: (1) the dichotomized use of DA
(positive vs. negative) where positive is both trace and 4+
or >300 mg/dl and (2) the use of a SCr cutoff (>132.6
μmol/l or 1.5 mg/dl) and not the eGFR to exclude patients with advanced CKD, although we achieved our
goal of excluding patients with CKD stages 4 and 5 (the
lowest eGFR value in our study sample was 35.5 ml/
min/1.73 m2). To address the first limitation, we performed a sensitivity analysis in which we analyzed trace
DA as negative and not positive and thus confirmed our
findings. This sensitivity analysis is important because a
trace reading on a urine dipstick may be influenced by
the urinary concentration (e.g. falsely trace = truly negative in highly concentrated urine) and we did not adjust
for urinary specific gravity or oliguria in our multivariate
models.
In summary, this study confirms the independent association between de novo DA and severe AKI in critically ill septic patients without advanced CKD. Our
study was not designed to evaluate the biomarker candidacy of de novo DA but serves to aid the design of future research in which albuminuria is quantitatively or
semiquantitatively measured and its prognostic value
ascertained in the presence or absence of subclinical
(preserved kidney function but positive damage biomarkers) and clinically apparent AKI. Key clinical outcomes such as mortality, the need for dialysis, a worsen-
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ing AKIN stage, incident CKD, or progressive CKD after
AKI need to be tested.
In conclusion, de novo DA within the first 24 h of ICU
admission was independently associated with severe AKI
in critically ill septic patients. Future, prospective studies
are required to test the utility of this widely available test
for the early detection of AKI and to determine its predictive potential.
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